| Titolo |
Pubblicato in |
Anno |
| COVID-19 vaccination in cancer patients: Immune responses one year after the third dose |
VACCINE |
2024 |
| Blood count and renal functionality assessments in the emergency section disclose morbidity and ortality in omicron COVID-19 patients: a retrospective study |
CLINICS AND PRACTICE |
2024 |
| The long-term Immunogenicity of mRNABNT162b third vaccine dose in solid organ transplant recipients |
VACCINES |
2024 |
| Small fibre neuropathy frequently underlies the painful long-COVID syndrome |
PAIN |
2024 |
| Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study |
THE AMERICAN JOURNAL OF MEDICINE |
2024 |
| COVID-19 affects serum brain-derived neurotrophic factor and neurofilament light chain in aged men. Implications for morbidity and mortality |
CELLS |
2023 |
| Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli |
VIRUSES |
2023 |
| Blood Biomarkers from the Emergency Department Disclose Severe Omicron COVID-19-Associated Outcomes |
MICROORGANISMS |
2023 |
| Evaluation of baff, april and cd40l in ocrelizumab-treated pwms and infectious risk |
BIOLOGY |
2023 |
| Tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) and pulmonary involvement in COVID-19 pneumonia |
BIOMOLECULES |
2023 |
| Neurofilament expression as a biomarker of post-COVID-19 sudden sensorineural hearing loss |
DISEASES |
2023 |
| Biomarkers of neurological damag. From acute stage to post-acute sequelae of covid-19 |
CELLS |
2023 |
| Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus |
VIRUSES |
2023 |
| Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyper-activation and associate with high platelet-lymphocyte and low platelet-neutrophil aggregates |
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS |
2023 |
| Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment |
JOURNAL OF CLINICAL MEDICINE |
2022 |
| Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study |
MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL |
2022 |
| Evaluation of the anti-proliferative activity of violacein, a natural pigment of bacterial origin, in urinary bladder cancer cell lines |
ONCOLOGY LETTERS |
2022 |
| B- and T-cell responses after SARS-CoV-2 vaccination in patients with multiple sclerosis receiving disease modifying therapies. Immunological patterns and clinical implications |
FRONTIERS IN IMMUNOLOGY |
2022 |
| Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients |
FRONTIERS IN IMMUNOLOGY |
2022 |
| Neurofilament assessment in patients with cervical dystonia |
PARKINSONISM & RELATED DISORDERS |
2022 |
